179 related articles for article (PubMed ID: 37350024)
1. Phosphaturic mesenchymal tumor: A chondromyxoid fibroma-like type.
Koga K; Iwasaki H; Nabeshima K
J Dermatol; 2023 Nov; 50(11):1484-1487. PubMed ID: 37350024
[TBL] [Abstract][Full Text] [Related]
2. Phosphaturic mesenchymal tumor without osteomalacia: additional confirmation of the "nonphosphaturic" variant, with emphasis on the roles of FGF23 chromogenic in situ hybridization and FN1-FGFR1 fluorescence in situ hybridization.
Sent-Doux KN; Mackinnon C; Lee JC; Folpe AL; Habeeb O
Hum Pathol; 2018 Oct; 80():94-98. PubMed ID: 29514106
[TBL] [Abstract][Full Text] [Related]
3. Phosphaturic mesenchymal tumor with chondromyxoid fibroma-like feature: an unusual morphological appearance.
Suryawanshi P; Agarwal M; Dhake R; Desai S; Rekhi B; Reddy KB; Jambhekar NA
Skeletal Radiol; 2011 Nov; 40(11):1481-5. PubMed ID: 21533894
[TBL] [Abstract][Full Text] [Related]
4. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
5. Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis.
Uchihashi K; Nishijima-Matsunobu A; Matsuyama A; Yamasaki F; Tanabe T; Uemura T; Aragane N; Yakushiji M; Yamamoto M; Aoki S; Toda S
Hum Pathol; 2013 Nov; 44(11):2614-8. PubMed ID: 23954138
[TBL] [Abstract][Full Text] [Related]
6. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia.
Bahrami A; Weiss SW; Montgomery E; Horvai AE; Jin L; Inwards CY; Folpe AL
Am J Surg Pathol; 2009 Sep; 33(9):1348-54. PubMed ID: 19609206
[TBL] [Abstract][Full Text] [Related]
7. Clinical, morphological and immunohistochemical analysis of 13 cases of phosphaturic mesenchymal tumor - A holistic diagnostic approach.
Chatterjee D; Bardia A; Pal R; Saikia UN; Bhadada SK; Radotra BD
Ann Diagn Pathol; 2021 Oct; 54():151783. PubMed ID: 34329884
[TBL] [Abstract][Full Text] [Related]
8. A 50-Year-Old Man Presenting with Multiple Bone Lesions and a Diagnosis of Phosphaturic Mesenchymal Tumor of the Femur.
Ren D; Wei K; Ifegwu I
Am J Case Rep; 2024 Feb; 25():e942810. PubMed ID: 38361352
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia.
Abate V; Vergatti A; De Filippo G; Damiano V; Menale C; D'Elia L; Rendina D
J Clin Endocrinol Metab; 2024 Feb; 109(3):e1006-e1011. PubMed ID: 38006315
[TBL] [Abstract][Full Text] [Related]
10. Phosphaturic Mesenchymal Tumors in the Head and Neck Demonstrate a Broad Clinical and Morphologic Spectrum.
Hulme KR; Mahar A; Campbell RG; Clifton-Bligh R; Gill AJ; Palme CE; Gupta R
Head Neck Pathol; 2022 Sep; 16(3):902-912. PubMed ID: 35119617
[TBL] [Abstract][Full Text] [Related]
11. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
Houang M; Clarkson A; Sioson L; Elston MS; Clifton-Bligh RJ; Dray M; Ranchere-Vince D; Decouvelaere AV; de la Fouchardiere A; Gill AJ
Hum Pathol; 2013 Dec; 44(12):2711-8. PubMed ID: 24060005
[TBL] [Abstract][Full Text] [Related]
12. Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant.
Yamada Y; Kinoshita I; Kenichi K; Yamamoto H; Iwasaki T; Otsuka H; Yoshimoto M; Ishihara S; Toda Y; Kuma Y; Setsu N; Koga Y; Honda Y; Inoue T; Yanai H; Yamashita K; Ito I; Takahashi M; Ohga S; Furue M; Nakashima Y; Oda Y
Histopathology; 2018 Feb; 72(3):460-471. PubMed ID: 28858396
[TBL] [Abstract][Full Text] [Related]
13. Tumor-induced osteomalacia: An overview.
Jadhav SS; Shah R; Patil V
Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101834. PubMed ID: 37935612
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant.
Shiba E; Matsuyama A; Shibuya R; Yabuki K; Harada H; Nakamoto M; Kasai T; Hisaoka M
Diagn Pathol; 2016 Mar; 11():26. PubMed ID: 26956379
[TBL] [Abstract][Full Text] [Related]
15. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?
Ledford CK; Zelenski NA; Cardona DM; Brigman BE; Eward WC
Clin Orthop Relat Res; 2013 Nov; 471(11):3618-25. PubMed ID: 23868423
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor.
Sun L; Dehner C; Kenney J; McNulty SM; Zhu X; Pfeifer JD; Maluf HM; Chrisinger JSA
Virchows Arch; 2021 Apr; 478(4):757-765. PubMed ID: 33151412
[TBL] [Abstract][Full Text] [Related]
17. Intracranial phosphaturic mesenchymal tumors. A case report and review of literature.
Kojima D; Ohba S; Abe M; Suzuki A; Horibe S; Tateya I; Hasegawa M; Hirose Y
Neuropathology; 2022 Oct; 42(5):453-458. PubMed ID: 35880350
[TBL] [Abstract][Full Text] [Related]
18. A Phosphaturic Mesenchymal Tumor Presenting as Reversible Metabolic Myopathy.
Abdulla M
Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):666-670. PubMed ID: 38725216
[TBL] [Abstract][Full Text] [Related]
19. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of tumor-induced osteomalacia causing by phosphaturic mesenchymal tumor of the foot.
Liu S; Zhou X; Song A; Huo Z; Wang Y; Xia W; Liu Y
Medicine (Baltimore); 2019 Jul; 98(27):e16296. PubMed ID: 31277164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
